AIL
WST icon

AGF Investments LLC’s West Pharmaceutical WST Stock Holding History

AGF Investments LLC’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,837
Closed -$862K – 524
2021
Q4 		$862K Buy
+1,837
New +$791K 0.07% 107
2021
Q2 		– Sell
-1,609
Closed -$453K – 513
2021
Q1 		$453K Sell
1,609
-437
-21% -$125K 0.05% 239
2020
Q4 		$580K Buy
2,046
+1,596
+355% +$448K 0.07% 241
2020
Q3 		$124K Buy
450
+326
+263% +$86.3K 0.01% 352
2020
Q2 		$28K Buy
124
+46
+59% +$9.04K ﹤0.01% 418
2020
Q1 		$12K Buy
78
+6
+8% +$924 ﹤0.01% 454
2019
Q4 		$11K Sell
72
-12
-14% -$1.75K ﹤0.01% 490
2019
Q3 		$12K Sell
84
-18
-18% -$2.48K ﹤0.01% 492
2019
Q2 		$13K Buy
+102
New +$12K ﹤0.01% 489
2018
Q2 		– Sell
-414
Closed -$36K – 880
2018
Q1 		$36K Buy
+414
New +$38.7K 0.01% 352
2017
Q1 		– Sell
-122
Closed -$11K – 802
2016
Q4 		$11K Buy
+122
New +$9.59K ﹤0.01% 543

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

AGF Investments LLC's WST Position: Q1 2022 in Review

AGF Investments LLC sold out of West Pharmaceutical (WST) in Q1 2022, closing a stake of 1,837 shares — an estimated $862K sold.

AGF Investments LLC first reported a position in WST in Q4 2016 and held it in 11 quarters. The position peaked at $862K in Q4 2021. 716 funds tracked by Wall St. Rank hold WST as of Q1 2022.

  • AGF Investments LLC reported no remaining West Pharmaceutical position as of Q1 2022 after selling out during the quarter.
  • AGF Investments LLC sold 1,837 West Pharmaceutical shares in Q1 2022, an estimated $862K.
  • AGF Investments LLC first reported a position in West Pharmaceutical in Q4 2016 and held it in 11 quarters.
  • AGF Investments LLC's West Pharmaceutical position peaked at $862K in Q4 2021.
  • 716 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2022.

Based on AGF Investments LLC's 13F filing for Q1 2022, filed 10 May 2022.